Patents Represented by Attorney Anthony G. Sitko PLC

Find this attorney in the Justia Lawyer Directory

  • Hemostasis analyzer and method
    Patent number: 7879615
    Abstract: A method and device for blood hemostasis analysis is disclosed. A blood sample is displaced to reach a resonant state. The resonant frequency of the blood sample is determined before, during and after a hemostasis process. The changes in the resonant frequency of the blood sample are indicative of the hemostasis characteristics of the blood sample.
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: February 1, 2011
    Assignee: Coramed Technologies, LLC
    Inventor: Hans Kautzky
  • Protocol and apparatus for determining heparin-induced thrombocytopenia
    Patent number: 7811792
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: October 12, 2010
    Assignee: Cora Healthcare, Inc.
    Inventors: Eli Cohen, Roslyn Cohen
  • Protocol for risk stratification of ischemic events and optimized individualized treatment
    Patent number: 7754489
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject.
    Type: Grant
    Filed: December 31, 2008
    Date of Patent: July 13, 2010
    Assignee: Cora Healthcare, Inc.
    Inventor: Eli Cohen
  • Method of evaluating patient hemostasis
    Patent number: 7732213
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of a patient hemostasis condition.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: June 8, 2010
    Assignee: CoraMed Healthcare, Inc.
    Inventors: Eli Cohen, Roslyn Cohen